UK trade association AXREM has extended its partnership with healthtech growth specialist Highland for another two years, with the aim of boosting growth across the UK’s diagnostic and health technology markets.

AXREM represents suppliers responsible for providing a large percentage of the diagnostic imaging and radiotherapy equipment used across National Health Service (NHS) hospitals, and has expanded its membership to include organisations in health IT, artificial intelligence (AI), digital pathology, teleradiology, and patient monitoring.

Highland – formerly Highland Marketing – works with healthtech companies to identify growth opportunities, build market presence, and connect directly with decision-makers.

Since the partnership began in 2024, the organisations have supported AXREM members in strengthening their communications, raising their profiles, and engaging NHS decision-makers, including through a webinar programme on brand development. The renewed agreement will build on this progress, introducing new initiatives to further enhance visibility and opportunities across the UK healthtech sector.

Sally Edgington, Chief Executive Officer at AXREM, commented on the collaboration: “Our members are delivering technologies that are fundamental to the future of healthcare. Extending our partnership with Highland will ensure we continue to equip them with the tools, insight, and support needed to tell their stories effectively and demonstrate their value to the health and care system.”

Mark Venables, Chief Executive Officer at Highland, added: “We’re very pleased to extend our collaboration with AXREM for another two years. AXREM plays a vital role in uniting and representing a sector that is crucial to the delivery of modern healthcare. Highland’s mission is to help healthtech organisations find new opportunities, convince target audiences, grow and make an impact. We look forward to engaging with more AXREM members to help them deliver.”

A new global healthcare technology platform, Lanas Healthcare Technologies, has recently launched with more than US$115 million in M&A funding and annual revenues exceeding $120 million.